Patents Assigned to Regenerer
-
Publication number: 20130259840Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.Type: ApplicationFiled: May 28, 2013Publication date: October 3, 2013Applicant: Tissue Regeneration Therapeutics Inc.Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D.S. Lickorish
-
Patent number: 8486143Abstract: A multi-region device for repair, regeneration or reconstruction in articular tissue injury such as torn ligaments and tendons is provided. The device comprises at least one degradable material and biocompatible non-degradable polymeric fiber-based material, in a three-dimensional braided scaffold. The two end sections are designed for attachment of the device at the site of implantation and are designed to allow bone cell ingrowth, and one or more middle regions are designed to allow ligament or tendon cell ingrowth.Type: GrantFiled: December 30, 2009Date of Patent: July 16, 2013Assignee: Soft Tissue Regeneration, Inc.Inventors: Cato T. Laurencin, Mark T. Aronson, Lakshimi Sreedharan Nair
-
Patent number: 8481311Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbors osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.Type: GrantFiled: June 11, 2009Date of Patent: July 9, 2013Assignee: Tissue Regeneration Therapeutics Inc.Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish
-
Publication number: 20110225879Abstract: A separation system and method for separating one or more solid fossil fuels from a contaminated source in a liquid medium, the system including primary separation means and secondary separation means, the primary and secondary separation means being arranged to operate with liquid media of differing specific gravities.Type: ApplicationFiled: October 14, 2009Publication date: September 22, 2011Applicant: ATH Regeneration LimitedInventors: Liam Fitzgerald, Peter Lawson, Mike Lenagh
-
Patent number: 8011800Abstract: The invention concerns a device for producing isotropic ambient light, comprising: at least one extended light source including several punctual light sources spaced apart along two orthogonal axes; a waveguide for propagating by total reflections in a propagating direction perpendicular to the plane, the light beams produced by the punctual light sources; and means for scattering the light in the waveguide output. The dimension of the waveguide along said propagating direction is further sufficient to allow the light intensity curve which is detected, for each light source, in the waveguide output along one of the two axes and in a detecting range corresponding to the waveguide output section along said axis, to have a maximum value (Imax) and a minimum value (Imin) which satisfy the following criterion of quasi-uniformity (Imax-Imoy) ?0.3Imoy and (Imoy-Imin) ?0.3Imoy, Imoy being the average value of the light intensity levels detected along said axis.Type: GrantFiled: March 20, 2007Date of Patent: September 6, 2011Assignees: Regenerer, Optical System & Research for Industry and Science OsyrisInventor: Jaouad Zemmouri
-
Publication number: 20110091516Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic gent to attract a desired cell.Type: ApplicationFiled: September 9, 2010Publication date: April 21, 2011Applicant: Regeneration Technologies, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell, JR.
-
Patent number: 7775995Abstract: The invention relates to a device for the generation of shock waves for medical therapy, having a shock source, an energy storage and a switch, wherein the energy storage is a capacitor with a high capacity.Type: GrantFiled: January 30, 2007Date of Patent: August 17, 2010Assignee: Tissue Regeneration Technologies LLCInventor: Axel Voss
-
Patent number: 7695443Abstract: The invention relates to a device for generating shock waves for medical therapy comprising two electrodes of a spark discharge section, wherein the device is filled with a liquid medium, and wherein the liquid medium comprises a colloidal suspension of a conducting, semiconducting, or polarizable substance in water.Type: GrantFiled: January 18, 2007Date of Patent: April 13, 2010Assignee: Tissue Regeneration Technologies, LLCInventor: Axel Voss
-
Publication number: 20090313869Abstract: The light production device includes at least one first light source associated with a principal waveguide. The principal waveguide includes an envelope for the propagation of the light, that has an index of refraction higher than the index of refraction of the internal part of the principal guide in contact with the envelope; the device includes optical injection means that are difference from the principal waveguide, the length of which is less than the length of the principal waveguide, and which allow at least a part of the light produced to be injected into said envelope of the principal waveguide, and diffusion means suitable for diffusing toward the exterior of the envelope, on at least a portion of the envelope of predefined length, at least a part of the light circulating in the envelope of the principal guide.Type: ApplicationFiled: July 27, 2007Publication date: December 24, 2009Applicants: Regenerer, Optical System & Research for Industry and Science OsyrisInventors: Jaouad Zemmouri, Jean Ringot
-
Publication number: 20090269318Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.Type: ApplicationFiled: June 11, 2009Publication date: October 29, 2009Applicant: Tissue Regeneration Therapeutics, Inc.Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D.S. Lickorish
-
Patent number: 7547546Abstract: Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC?/? progenitor cells, and is useful to grow and repair human tissues including bone.Type: GrantFiled: October 8, 2004Date of Patent: June 16, 2009Assignee: Tissue Regeneration Therapeutics Inc.Inventors: John E. Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony D. S. Lickorish
-
Publication number: 20080226612Abstract: The present disclosure covers compositions and method for the preparation and use of mixtures of adult stem/progenitor cell populations recovered and enriched from specific tissues with very limited attempts for their purification. Such mixtures of cell populations have improved therapeutic effectiveness in the treatment of certain diseases and tissue regeneration treatments over their more purified counterpart cell populations. Such mixtures of cell populations can be cryopreserved for future clinical use.Type: ApplicationFiled: August 2, 2006Publication date: September 18, 2008Applicant: Bio Regenerate, Inc.Inventors: Avraham Treves, Ronald Hoffman, Arnon Nagler, Ami Treves
-
Patent number: 7396923Abstract: A method for sulfonating compounds having one or more free hydroxyl functional groups and/or one or more optionally substituted primary or secondary functional groups, including treating the compounds with a complex of SO3-DMF in the presence of an acid capture agent.Type: GrantFiled: May 25, 2004Date of Patent: July 8, 2008Assignee: Organes, Tissues : Regeneration, Reparation, Remplacement- OTR3Inventors: Emmanuel Petit, Dulce Garcia-Papy, Véronique Barbier-Chassefiere
-
Patent number: 7182781Abstract: Disclosed herein are biomedical implants, and methods of using same, that are derived from bone. Particularly exemplified are implants having a tapered dowel shape that are useful for implantation in the spine, and especially in the cervical region of the spine. The taper of the implants disclosed herein provides an advantage over conventional implants, as it creates the proper support and angulation to maintain the proper curvature of the spine. Optionally, the implants taught herein are associated with osteogenic materials or other biomedical substances.Type: GrantFiled: November 1, 2000Date of Patent: February 27, 2007Assignee: Regeneration Technologies, Inc.Inventors: John R. Bianchi, Kevin C. Carter
-
Patent number: 7153518Abstract: Disclosed herein are novel injectable, biocompatible compositions, preferably, comprising a combination of particulate, processed tissue and a carrier. Specifically disclosed are compositions comprising acellular, pulverized dermis combined with at least one glycosaminoglycan and/or gelatin. The subject compositions provide for improved retention of the composition at the site of implantation. Also disclosed are medical applications using the disclosed compositions, such as cosmetic enhancement or filling in of voids due to abnormalities, injuries, surgery, or aging. In addition, kits comprising at least one container of a freeze-dried, particulate tissue and at least one container of a glycosaminoglycan, or crude platelet extract and used thereof as a wound treatment/dressing, are disclosed.Type: GrantFiled: August 27, 2002Date of Patent: December 26, 2006Assignee: Regeneration Technologies, Inc.Inventors: John F. Wironen, Chris Seid, Rebecca Jaw, Thien Doan, Gregg Ritter, Russell S. Donda
-
Patent number: 7131994Abstract: The present invention is directed to a composition comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. Also disclosed is a tissue graft or implant comprising a matrix suitable for implantation in humans, comprising defatted, shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier and dried in a predetermined shape. The composition and/or tissue graft or implant of the invention is usable in combination with seeded cells, a tissue growth factor, and/or a chemotactic agent to attract a desired cell.Type: GrantFiled: March 5, 2004Date of Patent: November 7, 2006Assignee: Regeneration Technologies, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell, Jr.
-
Patent number: 7048762Abstract: An implant composed substantially of cortical bone is provided for use in cervical Smith-Robinson vertebral fusion procedures. The implant is derived from allograft or autograft cortical bone sources, is machined to form a symmetrically or asymmetrically shaped (e.g. a substantially “D”-shaped) implant having a canal running therethrough according to methods of this invention, and inserted into the space between adjacent cervical vertebrae to provide support and induce fusion of the adjacent vertebrae. Osteogenic, osteoinductive or osteoconductive materials may be packed into the canal of the implant to expedite vertebral fusion and to allow autologous bony ingrowth.Type: GrantFiled: August 27, 1998Date of Patent: May 23, 2006Assignee: Regeneration Technologies, Inc.Inventors: Tom Sander, Kevin C. Carter
-
Patent number: 7048765Abstract: An implant composed substantially of cortical bone is provided for use in cervical Smith-Robinson vertebral fusion procedures. The implant is derived from allograft or autograft cortical bone sources, is machined to form a symmetrically or asymmetrically shaped (e.g. a substantially “D”-shaped) implant having a canal running therethrough according to methods of this invention, and inserted into the space between adjacent cervical vertebrae to provide support and induce fusion of the adjacent vertebrae. Osteogenic, osteoinductive or osteoconductive materials may be packed into the canal of the implant to expedite vertebral fusion and to allow autologous bony ingrowth.Type: GrantFiled: November 25, 2000Date of Patent: May 23, 2006Assignee: Regeneration Technologies, Inc.Inventors: Jamie M. Grooms, Kevin C. Carter, Tom Sander, David H. Dulebohn
-
Patent number: 7001430Abstract: The present invention is directed to an intermediate composition for producing a muscle tissue matrix suitable for implantation in humans, comprising shredded, allogeneic human muscle tissue that has been combined with an aqueous carrier, preferably a biocompatible acid solution, to form a muscle tissue slurry having a viscosity within the range of 1 centistoke to 20,000 centistokes measured at 25° C. In another aspect, the present invention is directed to a tissue implant comprising a human muscle tissue matrix.Type: GrantFiled: January 9, 2004Date of Patent: February 21, 2006Assignee: Regeneration Technologies, Inc.Inventors: C. Randal Mills, John R. Bianchi, Michael R. Roberts, David T. Cheung, Chandrasekaran Nataraj, John W. Howell, Jr.
-
Patent number: 6902932Abstract: The present invention provides a novel silk-fiber-based matrix having a wire-rope geometry for use in producing a ligament or tendon, particularly an anterior cruciate ligament, ex vivo for implantation into a recipient in need thereof. The invention further provides the novel silk-fiber-based matrix which is seeded with pluripotent cells that proliferate and differentiate on the matrix to form a ligament or tendon ex vivo. Also disclosed is a bioengineered ligament comprising the silk-fiber-based matrix seeded with pluripotent cells that proliferate and differentiate on the matrix to form the ligament or tendon. A method for producing a ligament or tendon ex vivo comprising the novel silk-fiber-based matrix is also disclosed.Type: GrantFiled: November 16, 2001Date of Patent: June 7, 2005Assignees: Tissue Regeneration, Inc., Trustees of Tufts CollegeInventors: Gregory H. Altman, David L. Kaplan, Rebecca L. Horan, David J. Horan